Pharmacokinetics of [14C]Ciclesonide After Oral and Intravenous Administration to Healthy Subjects

被引:0
|
作者
Ruediger Nave
Thomas D. Bethke
Sjoerd P. van Marle
Karl Zech
机构
[1] ALTANA Pharma AG,
[2] Pharma Bio-Research Group B.V.,undefined
来源
Clinical Pharmacokinetics | 2004年 / 43卷
关键词
Intravenous Administration; Budesonide; Oral Bioavailability; Fluticasone; Total Radioactivity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:479 / 486
页数:7
相关论文
共 50 条
  • [1] Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects
    Nave, R
    Bethke, TD
    van Marle, SP
    Zech, K
    [J]. CLINICAL PHARMACOKINETICS, 2004, 43 (07) : 479 - 486
  • [2] Pharmacokinetics of [14C]-labelled Losigamone and enantiomers after oral administration to healthy subjects
    Peeters, PAM
    Van Lier, JJ
    Van De Merbel, N
    Oosterhuis, B
    Wieling, J
    Jonkman, JHG
    Klessing, K
    Biber, A
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (01) : 45 - 53
  • [3] Pharmacokinetics of [14C]-labelled losigamone and enantiomers after oral administration to healthy subjects
    P. A. M. Peeters
    J. J. Van Lier
    N. Van De Merbel
    B. Oosterhuis
    J. Wieling
    J. H. G. Jonkman
    K. Klessing
    A. Biber
    [J]. European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 45 - 53
  • [4] Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjects
    Johnson, Theodore R.
    Tan, Weiwei
    Goulet, Lance
    Smith, Evan B.
    Yamazaki, Shinji
    Walker, Gregory S.
    O'Gorman, Melissa T.
    Bedarida, Gabriella
    Zou, Helen Y.
    Christensen, James G.
    Nguyen, Leslie N.
    Shen, Zhongzhou
    Dalvie, Deepak
    Bello, Akintunde
    Smith, Bill J.
    [J]. XENOBIOTICA, 2015, 45 (01) : 45 - 59
  • [5] Metabolism, excretion and pharmacokinetics of [14C]crizotinib following oral administration to healthy subjects
    Johnson, Theodore R.
    Goulet, Lance
    Smith, Evan B.
    Yamazaki, Shinji
    Walker, Gregory S.
    Tan, Weiwei
    Li, Chunze
    Ni, Yao
    Bedarida, Gabriella
    Brega, Nicoletta
    Dalvie, Deepak
    Smith, Bill J.
    [J]. DRUG METABOLISM REVIEWS, 2011, 43 : 77 - 77
  • [6] Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects
    Chen, Nianhang
    Wen, Lian
    Lau, Henry
    Surapaneni, Sekhar
    Kumar, Gondi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (03) : 789 - 797
  • [7] Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects
    Nianhang Chen
    Lian Wen
    Henry Lau
    Sekhar Surapaneni
    Gondi Kumar
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 69 : 789 - 797
  • [8] Pharmacokinetics, Disposition, and Biotransformation of [14C]Omecamtiv Mecarbil in Healthy Male Subjects after a Single Intravenous or Oral Dose
    Trivedi, Ashit
    Wahlstrom, Jan
    Mackowski, Mia
    Dutta, Sandeep
    Lee, Edward
    [J]. DRUG METABOLISM AND DISPOSITION, 2021, 49 (08) : 619 - 628
  • [9] Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis
    Stark, Jeffrey G.
    Noonan, Patrick K.
    Spencer, Robert H.
    Bhaduri, Sarbani
    O'Connor, Stephen J.
    Menzaghi, Frederique
    [J]. CLINICAL PHARMACOKINETICS, 2023, 62 (09) : 1231 - 1241
  • [10] Pharmacokinetics, Metabolism, and Excretion of Intravenous [14C]Difelikefalin in Healthy Subjects and Subjects on Hemodialysis
    Jeffrey G. Stark
    Patrick K. Noonan
    Robert H. Spencer
    Sarbani Bhaduri
    Stephen J. O’Connor
    Frédérique Menzaghi
    [J]. Clinical Pharmacokinetics, 2023, 62 : 1231 - 1241